Cita APA (7a ed.)

Patra, T., Meyer, K., Ray, R. B., Kanda, T., & Ray, R. (2021). Akt inhibitor augments anti-proliferative efficacy of a dual mTORC1/2 inhibitor by FOXO3a activation in p53 mutated hepatocarcinoma cells. Nature Publishing Group.

Cita Chicago Style (17a ed.)

Patra, Tapas, Keith Meyer, Ratna B. Ray, Tatsuo Kanda, y Ranjit Ray. Akt Inhibitor Augments Anti-proliferative Efficacy of a Dual MTORC1/2 Inhibitor by FOXO3a Activation in P53 Mutated Hepatocarcinoma Cells. Nature Publishing Group, 2021.

Cita MLA (8a ed.)

Patra, Tapas, et al. Akt Inhibitor Augments Anti-proliferative Efficacy of a Dual MTORC1/2 Inhibitor by FOXO3a Activation in P53 Mutated Hepatocarcinoma Cells. Nature Publishing Group, 2021.